Oncology
News
Sequential CRT, immunotherapy nets high PFS in node-positive cervical cancer
More than four in five patients were alive and free of disease progression a year after receiving chemoradiotherapy followed by ipilimumab, and...
News
Large state disparities seen for lung cancer screening
Lung cancer screening for high-risk individuals remains low.
Opinion
How should we monitor for ovarian cancer recurrence?
Tumor marker assessment in the surveillance period may be more of a hindrance than a help.
News
Survey: Cancer-related pain, opioid use up since 2018
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
News
Early lenalidomide may delay progression of smoldering myeloma
Researchers said the findings from the phase 3 study support early treatment as the new standard of care in patients with high-risk smoldering...
News
Not all lung cancer patients receive treatment
Reasons include metastasis and refusal, and rates by state vary from 8% to 30%, the American Lung Association reports.
Conference Coverage
Nivolumab-ipilimumab combo has ‘robust’ clinical benefit in sorafenib-treated HCC patients
BOSTON – Manageable hepatic adverse events for combination, now under evaluation in a phase 3 trial and accepted for priority review by the FDA....
Conference Coverage
Combo produces disappointing PFS, promising OS in metastatic colorectal cancer
NATIONAL HARBOR, MD. – Combination avelumab and cetuximab plus oxaliplatin, leucovorin, and 5-fluorouracil failed to meet the primary endpoint for...
News
Lorlatinib induces deep responses in ROS1-positive NSCLC
Among 40 crizotinib-pretreated patients, 14 patients (35%) had an objective response on lorlatinib, with a median duration of response of 13.8...
Conference Coverage
Direct-acting antiviral treatment linked to lower mortality in patients with HCC history
BOSTON – Reduced mortality in HCC patients with complete response apparently driven by achievement of sustained...
